Connect with us

Politics

New Jersey Lawmakers Approve Marijuana Legalization

Published

on

New Jersey got one step closer to legalizing marijuana on Monday after lawmakers approved an adult-use legalization bill in a joint session of Senate and Assembly committees.

A total of three separate cannabis bills were approved at the hearing: one to fully legalize marijuana, one to expand the state’s existing medical cannabis program and another that would create a system to speed up expungements for people who’ve been convicted for low-level marijuana offenses.

After about four hours of testimony on the full legalization bill, the panels cast votes on that piece of legislation, with it being approved 7-4 with two abstentions on the Senate side. The Assembly panel then signed off by a vote of 7-3 with one abstention.

“Today’s Senate and Assembly votes are a victory for common sense and for sound public policy in New Jersey,” NORML Executive Director Erik Altieri said in a press release. “We look forward to lawmakers on the Assembly and Senate floors acting swiftly to approve this legislation to send to Governor Murphy to sign into law.”

“New Jersey holds the dubious distinction of ranking second in the nation in per capita annual marijuana arrests. This policy disproportionately impacts young people of color, violates civil liberties, and is an egregious waste of public resources that can be reprioritized elsewhere. The people of New Jersey are ready to move forward. Their representatives should approve this legislation this year and replace the failed practice of prohibition with the sensible policy of legalization and regulation.”

The other two bills—to expand New Jersey’s medical cannabis program and expedite expungements—were also approved by both panels.

Sen. Nicholas Scutari (D), the main sponsor of the legalization proposal, kicked off the hearing by touting the economic and criminal justice benefits of ending prohibition.

He was followed by a large mix of legalization supporters and opponents, including representatives from the Drug Policy Alliance (DPA), Latino Justice and law enforcement associations.

“Today’s vote is a step in the right direction for New Jersey,” DPA’s Roseanne Scotti said in a press release. “For too long, New Jersey’s marijuana laws have harmed families and communities, particularly communities of color. African Americans are three times more likely to be arrested for marijuana than whites despite similar rates of use, and anecdotal evidence suggests similar disparities for Latinos. Legalizing marijuana for adult-use is essential to help repair these wrongs.”

Former U.S. Rep. Patrick Kennedy (D-RI), who co-founded the anti-legalization group Smart Approaches to Marijuana, spoke out against the reform legislation and sparred with lawmakers in especially heated testimony.

Assembly Appropriations Chair John Burzichelli (D) commented on the “long road” to reform and said “we are on the verge of something very significant.”

He also talked about the failures of prohibition and said keeping marijuana “in the shadows” doesn’t “serve us.”

“I believe this is a good bill and one that will change the lives of tens of thousands of New Jersey residents for the better,” Assemblywoman Annette Quijano said.

“Lets face it: legalizing, regulating and taxing cannabis will be an economic driver that will allow us to reinvest in our communities,” she later said.

The marijuana reform proposals will now head for full floor votes.

“We will continue working the bills towards passage to create a well-regulated and inclusive marijuana industry that is rooted in social and economic justice,” Assembly Speaker Craig Coughlin said in a press release.

Pending approval by both full chambers the legislation will go on to Gov. Phil Murphy (D), whose office released a statement Monday affirming that the governor “remains committed to legalizing adult-use marijuana, a critical step in eliminating racial disparities in our criminal justice system.”

Separately, the governor said he’s “very happy” that legalization is moving forward, though he declined to get into the specifics of the legislation.

Murphy’s administration has expressed reservations about certain aspects of the bill—namely who gets to be in charge of regulating the commercial marijuana system and how sales are taxed. The governor reportedly wanted the executive branch to have more regulatory control and called for a steeper tax than the 12 percent rate included in the legislation.

It could be a matter of weeks before Murphy will have the chance to sign the legislation.

“New Jersey is one step closer to replacing marijuana prohibition with sensible regulation,” Kate Bell, general counsel for the Marijuana Policy Project, said in a press release. “Arresting adult cannabis consumers is a massive waste of law enforcement officials’ time and resources, and it does nothing to improve public health or safety.”

“Prohibition forces marijuana sales into the underground market, where it is impossible to control them. Under the proposed regulated system, businesses will be governed by strict rules, and authorities will be empowered to make sure those rules are being followed.”

Besides legalizing cannabis for adult use—the centerpiece of the legislative package—the committees also approved a bill to expand New Jersey’s medical marijuana system. Under the proposal, the list of qualifying medical conditions would be expanded and patients would be able possess an extra half ounce of cannabis during a 30-day window, among other smaller policy changes.

Elsewhere in the Legislature on Monday, a separate Senate committee also approved that bill, which is meant to simplify the process of qualifying for medical cannabis and obtaining it. The bill passed 7-1 in that panel. One state senator on the committee did not vote.

Lastly, while there’s an expungement element included in the broad legalization bill, a separate bill to expedite expungements for low-level marijuana offenses also passed.

You can read the text of the latest versions of all three bills here.

UPDATE: This story has been updated with the latest information on votes for all three marijuana bills and to include comment from Drug Policy Alliance, Marijuana Policy Project and NORML.

Read The Marijuana Bills New Jersey Lawmakers Will Vote On Next Week

Photo courtesy of Max Pixel.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE and attn.

Politics

Bipartisan Lawmakers Tell DEA To Let Researchers Study Marijuana From Dispensaries

Published

on

A bipartisan coalition of lawmakers from the House and Senate sent a letter to the Justice Department on Friday, requesting a policy change allowing researchers to access marijuana from state-legal dispensaries to improve studies on the plant’s benefits and risks.

The letter, led by Rep. Harley Rouda (D-CA) and Sen. Brian Schatz (D-HI), cites feedback from federal health agencies, which have said that existing restrictions on cannabis have inhibited research. One problem in particular is that there’s only one federally authorized manufacturer of research-grade marijuana.

While the Drug Enforcement Administration (DEA) said that it is in the process of approving additional manufacturers, it’s been more than three years since they first announced that applications for more growers would be accepted and, more recently, the agency said it would have to develop alternative rules to approve proposals that have been submitted.

“At the same time, the status quo does not address a barrier to research raised by both [the National Institutes of Health] and [the Food and Drug Administration],” the lawmakers wrote in the new letter. That barrier is a ban on researchers being able to obtain marijuana from dispensaries.

“Both agencies recommended that researchers should be able to obtain cannabis from state-legal sources,” the letter states.

Further, the lawmakers said that there are “problems in industry development of licensed drugs with data from products obtained from third-parties, such as the University of Mississippi.”

“In many states, cannabis law and regulations already provide for licensing of industrial manufacturing activities, and products are available for medical use in those states, but not for research leading to FDA licensure,” they wrote.

“There is a need for a greater diversity of cannabis products so that research on benefits and risks reflects the realities of what consumers and patients are using. NIH and FDA have strongly recommended streamlining the process for conducting research and product development activities with cannabis and other Schedule I substances, and that the DEA take action to assure that interpretations of processes and policies are universally applied in local DEA jurisdictions.”

The lack of chemical diversity in the federal government’s cannabis supply has been repeatedly pointed out. One study found that the research-grade cannabis is more similar to hemp than marijuana in commercial markets.

To resolve the research issues, the coalition made two recommendations: 1) to amend internal policy “so as to allow researchers with Schedule I licenses to obtain cannabis-derived products from state authorized dispensaries for research purposes” and 2) issue guidance clarifying that hemp researchers do not need a DEA license to obtain and study hemp because it was federally legalized under the 2018 Farm Bill.

The letter requests a response from DEA by December 20.

A total of 21 members of Congress signed the letter, including Sens. Kamala Harris (D-CA) and Cory Gardner (R-CO), along with Reps. Earl Blumenauer (D-OR), Barbara Lee (D-CA) Matt Gaetz (R-FL) and Joe Kennedy (D-MA).

“Our nation’s cannabis research laws are archaic,” Rouda said in a press release. “Forty-seven states have legalized some form of cannabis consumption—we must ensure our federal agencies and other licensed institutions can comprehensively study the benefits and risks of cannabis products.”

“I thank Senator Schatz, and my colleagues on both sides of the aisle, for joining me to make this common-sense request,” he said. “It’s time to bring our drug research policies into the 21st century.”

Attorney General William Barr received a similar letter from lawmakers about the need to expand the number of federally authorized marijuana cultivators in April.

Read the lawmakers’ full letter on expanding marijuana research below:

FINAL Letter to DOJ Re. Can… by Marijuana Moment on Scribd

People Are Skipping Sleep Aids In Favor of Marijuana, Study Reports

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Oregon Activists Begin Signature Gathering For 2020 Drug Decriminalization Initiative

Published

on

Oregon activists have begun collecting signatures for a statewide initiative to decriminalize possession of all drugs.

Three months after petitioners quietly submitted the proposed ballot measure—titled the “Drug Addiction Treatment and Recovery Act” (DATRA)—the signature gathering process has started, with organizers deployed to Portland to raise support.

A long road lies before the activists, who need to collect 112,020 valid signatures from voters in order to qualify for the 2020 ballot. Funding and polling will decide whether they mount a full push for the decriminalization measure in the months to come.

To that end, their efforts are being helped by David Bronner, CEO of the soap company Dr. Bronner’s, who told Marijuana Moment on Thursday that he will be investing $250,000 in the decriminalization campaign. An additional $500,000 will go to a separate Oregon initiative to legalize psilocybin for therapeutic purposes.

The Drug Policy Alliance (DPA), which backed Oregon’s successful marijuana legalization initiative in 2014, is also supporting this new effort to make low-level drug possession an infraction punishable by a $100 fine with no jail time, rather than a misdemeanor. It remains to be seen how involved in the campaign DPA will be, however.

Peter Zuckerman, a chief petitioner for the decriminalization initiative, told OregonLive on Thursday that it’s not guaranteed that the campaign will proceed and that much rides on how much money the group can raise, whether there’s public support for the reform move and how staff recruitment comes together.

He said the main thrust of the measure is to take a “health-based approach to drug addiction rather than a criminal justice-based approach.”

The proposal caught the attention of Oregon’s teachers’ union, which said that it supports decriminalizing drug possession but wrote in a comment submitted to the secretary of state in October that it was not taking an official position because it’s concerned about another provision that would shift cannabis tax revenue away from schools.

DATRA would make it so most of that revenue would be used to fund addiction treatment programs.

At the same time that activists are collecting signatures and weighing whether to move ahead with the broad decriminalization initiative, another advocacy group is pushing for a measure to legalize psilocybin for therapeutic use, allowing individuals to receive treatment with the psychedelic fungus at licensed health facilities. The group launched its signature drive in September.

Advocates in Portland are also hoping to advance a local measure to decriminalize psilocybin and other psychedelics such as ayahuasca and ibogaine.

Bronner wrote in a blog post that the decriminalization and therapeutic psilocybin legalization campaigns are “already coordinating closely and conserving resources on the statewide signature drive.”

He told Marijuana Moment that “we see this as the perfect one two punch in Oregon, legalizing psilocybin therapy that has so much promise for treating drug addiction, at the same time Oregon shifts to a treatment not jail approach.”

“And 100 percent confident it’s coming together,” he said.

All of this comes amid a national movement to decriminalize psychedelics, with activists in almost 100 cities across the U.S. considering pushing for reduced penalties for substances such as psilocybin and ayahuasca. Decriminalize Nature, which is aiding in and tracking these efforts, is also receiving donations from Bronner, he said.

Decriminalization is also gaining traction on the national stage, with two presidential candidates—South Bend, Indiana Mayor Pete Buttigieg and Rep. Tulsi Gabbard (D-HI)—voicing support for the policy change. Former Housing and Urban Development Secretary Julián Castro, another candidate, recently said that he’s open to broad decriminalization, while entrepreneur Andrew Yang backs decriminalizing opioids.

Scientist Talks Benefits Of Psychedelics At Federal Health Agency Event

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

North Dakota Activists Submit Measure To Legalize Marijuana In 2020

Published

on

North Dakota activists submitted a measure to legalize marijuana for adult use to state officials on Thursday, an organizer confirmed to Marijuana Moment.

Legalize ND, the group behind the proposed statutory initiative, delivered the measure to the secretary of state’s office. It’s expected to be validated within days, after which point petitions will be distributed to collect signatures in support of qualifying for the 2020 ballot.

It’s been about a year since organizers began working on the measure, which would allow adults 21 and older to possess and purchase cannabis for personal use. The proposal is more narrowly tailored than a legalization initiative from the same organization that voters rejected in 2018, however.

The previous version didn’t include any restrictions on cultivation or possession, and it didn’t involve a licensing scheme. By contrast, the new measure would prohibit home cultivation, limit possession to two ounces, impose a 10 percent excise tax and establish a regulatory body to approve licenses for marijuana businesses.

“One of the largest complaints from last time was the mantra of ‘poorly written,'” Legalize ND’s David Owen told Marijuana Moment in a phone interview. “They targeted the lack of legal experience from our team and they targeted a lack of ‘qualified lawyers’ to be drafting language that would go into the state’s statutory law.”

But he said he’s confident the campaign will be successful this time around, in part because they spent months drafting the language with the North Dakota Legislative Council.

Asked what he’d say to voters still on the fence about legalization, Owen replied that it would depend on what their initial concerns were:

“If it’s a concern over home grow, well it’s simple, we don’t have that anymore. If it’s a concern of people having too much, we have a reasonable possession limit now—in their eyes, I still think possession limits are fundamentally arbitrary, but they wanted a possession limit so we have that now. If people go, ‘well what about the quality of the language?’ I can point to how it’s literally written by Legislative Council, so either every attorney who works for the state of North Dakota is incompetent or this is well written.”

In order to qualify for next year’s ballot, the group must collect 13,452 valid signatures from voters before July 6, 2020.

“I think the most important thing isn’t what it would do, but what it would stop from happening,” Owen told local radio station KFGO on Wednesday. “We currently have a system where people are unable to find a job because of a criminal record, we have a system where people are continuing to get marijuana charges and lose their housing, we have families being separated because of parents losing custody over their children for marijuana charges. That all stops when this is legalized.”

Listen to Owen’s radio interview about the new marijuana ballot measure below:

Internal polling that received outside funding, which Owen said cannot be publicly released because of the wishes of the donor, shows the initiative is “slightly ahead” among voters.

In an earlier interview with Marijuana Moment in February, Owen said that it’s “very probable that we can do it” this time around, but much of that depended on the extent to which opposition campaigns are involved and how much funding outside groups are able to offer.

Currently, North Dakota has a medical cannabis program, and the governor signed legislation in May decriminalizing low-level marijuana possession.

Marijuana Summit Will Give Virginia Governor ‘More Tools’ To Back Legalization, Attorney General Says

Photo courtesy of Philip Steffan.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!